iBio Inc (IBIO)
2.64
+0.19
(+7.76%)
USD |
NYAM |
Nov 22, 16:00
2.64
0.00 (0.00%)
After-Hours: 20:00
iBio Revenue (Annual): 0.225M for June 30, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 0.225M |
June 30, 2023 | |
June 30, 2022 | 1.884M |
June 30, 2021 | 2.371M |
June 30, 2020 | 1.638M |
June 30, 2019 | 2.018M |
June 30, 2018 | 0.444M |
June 30, 2017 | 0.394M |
June 30, 2016 | 0.948M |
Date | Value |
---|---|
June 30, 2015 | 1.851M |
June 30, 2014 | 0.205M |
June 30, 2013 | 1.007M |
June 30, 2012 | 1.277M |
June 30, 2011 | 0.5201M |
June 30, 2010 | |
June 30, 2009 | 1.177M |
June 30, 2008 | 0.9871M |
June 30, 2007 | 0.8963M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.225M
Minimum
2024
2.371M
Maximum
2021
1.530M
Average
1.761M
Median
Revenue (Annual) Benchmarks
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 4.490M |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Nanoviricides Inc | -- |